SpeedWeed

AUGUST 4, 2021

Medical Cannabis Australia, the company she founded, just obtained its cultivation and manufacture licenses from the Office of Drug Control (ODC) in April of this year. High Times chatted with Bentley to learn more about the personal experience that caused her to be passionate about medical cannabis. During a social trip to the U.S.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

DECEMBER 6, 2021

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Dr. Jacobs was responsible for building the CMC team and supply chain / operations at Ardelyx.

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

Cannabis Law Report

MARCH 25, 2020

OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM ® Biotechnologies, Inc. CEO Dr. Stuart Titus.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Clinical Trials 59

Cannabis Law Report

SEPTEMBER 3, 2019

Awarded Australian Cannabis Industry 2019 Innovation Award. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

DECEMBER 21, 2021

Engaging in these markets required Dalrada’s perseverance to overcome continual supply chain delays created by the pandemic that is now in its second year. Ignite products are ecologically responsible and do not require additional wastewater treatment. The renewable clean energy market is projected to reach $1,977.6

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Advance to FDA IND-enabling studies to support human clinical studies. Previously the Company announced that it had secured FDA Orphan Drug Designation for cepharanthine in the treatment of esophageal cancer.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

The Cannigma

MAY 7, 2021

Listen & Subscribe: When it comes to regulating and producing medicalized cannabis products, different countries have a variety of approaches. The American field of medicalized cannabis has followed a very different path to Europe. . The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

SEPTEMBER 9, 2021

DUBLIN–(BUSINESS WIRE)–The “Global Legal Cannabis Market 2021-2028” report has been added to ResearchAndMarkets.com’s offering. The global legal cannabis market size is expected to reach USD 91.5 have gone a step further and legalized the recreational use of cannabis. over the forecast period.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

JULY 15, 2022

The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. Secrecy has surrounded a media visit to Queensland’s first licensed cannabis farm, which is nearing completion on the Sunshine Coast.

Medicine 52

Medicine Patients Media Supply Chain 52

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

Cannabis Law Report

OCTOBER 3, 2019

Cannabis was high on the regulatory agenda in September, with two significant developments: 1. The Australian Capital Territory ( ACT ) voted to legalise the personal possession and cultivation of cannabis. The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Cannabis Law Report

AUGUST 30, 2019

Ballot initiative campaigns to approve adult-use and medical cannabis, respectively, moved closer to appearing on the 2020 ballot in Arizona and Idaho, while a similar effort to put the issue of adult-use cannabis to Ohio voters has met with legal challenges from the State Election Board. The SAFE Banking Act (H.R.

Banking 45

Banking Research and Development Legislation Programs 45